Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug ...

India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald ...

Pharma stocks lit up Dalal Street on Tuesday as President Donald Trumps remarks on drug pricing sent mixed signals to global ...

Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this trend.

Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that ...

The sudden focus on pharmaceutical shares is due to a new executive order signed by US President Donald Trump on Monday.

Pharma stocks faced a downturn after US President Donald Trump revealed plans to slash drug prices. Sun Pharmaceuticals and ...

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

Mark Mobius discusses investment strategies amidst geopolitical tensions and market dynamics. He highlights India's potential ...

Pharma sector stocks in the Indian stock market showed strong resilience on Monday despite initial pressure due to the ...